Artivion (AORT) EBT Margin (2010 - 2026)
Artivion posted quarterly EBT Margin of 0.29% for Q1 2026, up 261.0% year-on-year from 0.08% in Q1 2025, and down 94.83% on a QoQ basis from 5.64% in Q4 2025.
Artivion (AORT) has 17 years of EBT Margin data on file, last reported at 0.29% in Q1 2026.
- For the quarter ending Q1 2026, EBT Margin rose 261.0% year-over-year to 0.29%; the trailing twelve-month figure through Mar 2026 stood at 3.8% (up 959.0% YoY), and the FY2025 full-year result was 3.35%, up 528.0% from the prior year.
- EBT Margin for Q1 2026 stood at 0.29%, down from 5.64% in the prior quarter.
- Across five years, EBT Margin topped out at 13.12% in Q1 2024 and bottomed at 17.06% in Q4 2024.
- The 5-year median for EBT Margin is 2.32% (2025), against an average of 2.31%.
- Peak annual rise in EBT Margin reached 2439 bps in 2022, while the deepest fall reached 2731 bps in 2022.
- A 5-year view of EBT Margin shows it stood at 4.13% in 2022, then plunged by 115 bps to 0.63% in 2023, then sank by 2604 bps to 17.06% in 2024, then soared by 133 bps to 5.64% in 2025, then plunged by 95 bps to 0.29% in 2026.
- The last three EBT Margin figures came in at 0.29% (Q1 2026), 5.64% (Q4 2025), and 6.22% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 12.98% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 14.12% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 15.57% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 22.33% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 27.84% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 4.87% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 22.61% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.84% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.17% |
| 10 | Artivion | 1.02 Bn | 961.00 Mn | 75.45 Mn | 0.29% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.29% |
| Dec 31, 2025 | 5.64% |
| Sep 30, 2025 | 6.22% |
| Jun 30, 2025 | 3.08% |
| Mar 31, 2025 | -2.32% |
| Dec 31, 2024 | -17.06% |
| Sep 30, 2024 | -1.32% |
| Jun 30, 2024 | -2.48% |
| Mar 31, 2024 | 13.12% |
| Dec 31, 2023 | -0.63% |
| Sep 30, 2023 | -10.72% |
| Jun 30, 2023 | -2.98% |
| Mar 31, 2023 | -10.72% |
| Dec 31, 2022 | 4.13% |
| Sep 30, 2022 | -16.31% |
| Jun 30, 2022 | -4.11% |
| Mar 31, 2022 | -3.15% |
| Dec 31, 2021 | -20.26% |
| Sep 30, 2021 | 11.00% |
| Jun 30, 2021 | -2.87% |
| Mar 31, 2021 | -6.33% |
| Dec 31, 2020 | -0.14% |
| Sep 30, 2020 | -6.42% |
| Jun 30, 2020 | -8.86% |
| Mar 31, 2020 | -12.25% |
| Dec 31, 2019 | -6.92% |
| Sep 30, 2019 | -1.46% |
| Jun 30, 2019 | 3.85% |
| Mar 31, 2019 | -2.44% |
| Dec 31, 2018 | -8.88% |
| Sep 30, 2018 | 3.26% |
| Jun 30, 2018 | -0.20% |
| Mar 31, 2018 | -11.15% |
| Dec 31, 2017 | -14.07% |
| Sep 30, 2017 | 0.05% |
| Jun 30, 2017 | 8.66% |
| Mar 31, 2017 | 3.87% |
| Dec 31, 2016 | 8.35% |
| Sep 30, 2016 | 10.45% |
| Jun 30, 2016 | 8.21% |
| Mar 31, 2016 | 14.08% |
| Dec 31, 2015 | -2.72% |
| Sep 30, 2015 | 7.79% |
| Jun 30, 2015 | 0.47% |
| Mar 31, 2015 | -5.24% |
| Dec 31, 2014 | 4.37% |
| Sep 30, 2014 | 7.95% |
| Jun 30, 2014 | 6.90% |
| Mar 31, 2014 | 4.86% |
| Dec 31, 2013 | 36.33% |
| Sep 30, 2013 | 12.78% |
| Jun 30, 2013 | 8.16% |
| Mar 31, 2013 | 8.57% |
| Dec 31, 2012 | -28.79% |
| Sep 30, 2012 | 7.85% |
| Jun 30, 2012 | 16.89% |
| Mar 31, 2012 | 4.89% |
| Dec 31, 2011 | 9.42% |
| Sep 30, 2011 | 7.72% |
| Jun 30, 2011 | 12.86% |
| Mar 31, 2011 | 8.40% |
| Dec 31, 2010 | 10.67% |
| Sep 30, 2010 | -16.13% |
| Jun 30, 2010 | 17.34% |